Vacek, M. M., Schäffer, A. A., Davis, J., Fischer, R. E., Dale, J. K., Adams, S., . . . Puck, J. M. (2006). HLA B44 is associated with decreased severity of autoimmune lymphoproliferative syndrome in patients with CD95 defects (ALPS type Ia). Clinical immunology (Orlando, Fla.), 118(1), 59.
Style de citation ChicagoVacek, Marla M., Alejandro A. Schäffer, Joie Davis, Roxanne E. Fischer, Janet K. Dale, Sharon Adams, Stephen E. Straus, et Jennifer M. Puck. "HLA B44 Is Associated with Decreased Severity of Autoimmune Lymphoproliferative Syndrome in Patients with CD95 Defects (ALPS Type Ia)." Clinical Immunology (Orlando, Fla.) 118, no. 1 (2006): 59.
Style de citation MLAVacek, Marla M., et al. "HLA B44 Is Associated with Decreased Severity of Autoimmune Lymphoproliferative Syndrome in Patients with CD95 Defects (ALPS Type Ia)." Clinical Immunology (Orlando, Fla.), vol. 118, no. 1, 2006, p. 59.